BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:aa31ccd78f25ae263d816dac219a57a4
DTSTAMP:20261006T220206Z
SUMMARY:WFI Infection & Immunity Seminar Series: Neutralising antibodies ag
 ainst SARS-CoV-2 variants – the effects of boosting and waning on protec
 tion against Covid-19 – Dr Emma Wall
DESCRIPTION:Please join us for the next instalment of the Wright Fleming In
 stitute Seminar Series (Winter/Spring)\n\nHybrid Seminar\nDr Emma Wall MRC
 P DTM&H MRes PhD\nSenior Clinical Research Fellow\, Francis Crick Institut
 e & University College London Hospitals Biomedical Research Centre\nConsul
 tant in Infectious Diseases and Acute Medicine ULCH\nEmma is a clinician s
 cientist in Infectious Diseases. She holds a 2 year senior clinical resear
 ch fellowship\, jointly appointed between the Francis Crick Institute and 
 UCLH Biomedical Research Centre. Emma the leads the Legacy study\, a prosp
 ective observational cohort study investigating SARS‑CoV‑2 susceptibil
 ity\, transmission and disease severity. \nShe graduated from the Universi
 ty of Bristol\, following UK-based post-graduate training in medicine\, sh
 e worked in Northern Australia\, Uganda and Cambridge prior to higher spec
 ialist training in infection and internal medicine in North West London. E
 mma did her PhD at the Liverpool School of Tropical Medicine and the Malaw
 i Liverpool Wellcome Trust Clinical Research Programme in Malawi\, studyin
 g clinical management and epidemiology of bacterial meningitis in Malawian
  adults. Prior to joining the Francis Crick Institute as a post-doctoral c
 linical fellow\, she was a NIHR clinical lecturer in Infection at UCL. Her
  primary research interest is invasive infection in HIV infected adults in
  low and middle income settings\, with a particular focus on host-pathogen
  interactions\, neurological infection and improving clinical outcomes fro
 m infections caused by Streptococcus pneumoniae. More recently she has foc
 ussed on evaluation of humoral and cell-mediated responses to COVID-19 vac
 cines in healthy adults and immunocompromised patient groups within the Le
 gacy study. \nPlease join us (in person Cockburn LT) \nand via Microsoft T
 eams meeting Click here to join the meeting\n\n\n
URL:https://www.imperial.ac.uk/events/144010/neutralising-antibodies-agains
 t-sars-cov-2-variants-the-effects-of-boosting-and-waning-on-protection-aga
 inst-covid-19-dr-emma-wall/
DTSTART;TZID=Europe/London:20220208T123000
DTEND;TZID=Europe/London:20220208T133000
LOCATION:Cockburn Lecture Theatre\, 1st Floor\, Queen Elizabeth The Queen M
 other Wing\, St Mary's Campus\, Imperial College London\, London\, W2 1NY\
 , United Kingdom
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
DTSTART:20220208T123000
TZNAME:GMT
TZOFFSETTO:+0000
TZOFFSETFROM:+0000
END:STANDARD
END:VTIMEZONE
END:VCALENDAR